The Circulation Journal Official Impact Factor and the Most Frequently Cited Papers in 2024
Article ID: CJ-66-0241
Details
Article ID: CJ-66-0241
Dear Colleagues,
On behalf of the Circulation Journal, I would like to report its official 2024 Impact Factor and the related information in detail as follows:
I would like to report that Circulation Journal has earned an official 2024 Impact Factor of 3.7 (2023: 3.1). The official ranking places Circulation Journal the 55th out of 230 journals in the Cardiac & Cardiovascular Systems category in 2024 JCR Science Citation Index Expanded Edition (67th out of 220 journals in 2023), ranking in the top 25% in Q1. I would like to ask readers to use Circulation Journal papers as reference papers in your future submission of manuscripts to any journals.
The following papers, published in 2022–2023, are the top 29 most frequently cited papers in 2024, thereby substantially contributing to the 2024 Impact Factor of the Journal. Numbers in the parenthesis denote the number of citations in 2024.
1. (56) Hokimoto S, Kaikita K, Yasuda S, Tsujita K, Ishihara M, Matoba T, et al.; Japanese Circulation Society and Japanese Association of Cardiovascular Intervention and Therapeutics and Japanese College of Cardiology Joint Working Group. JCS/CVIT/JCC 2023 guideline focused update on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunction. Circ J 2023; 87: 879–936.
2. (52) Makita S, Yasu T, Akashi YJ, Adachi H, Izawa H, Ishihara S, et al.; Japanese Circulation Society/the Japanese Association of Cardiac Rehabilitation Joint Working Group. JCS/JACR 2021 guideline on rehabilitation in patients with cardiovascular disease. Circ J 2023; 87: 155–235.
3. (37) Ono K, Iwasaki YK, Akao M, Ikeda T, Ishii K, Inden Y, et al.; Japanese Circulation Society and Japanese Heart Rhythm Society Joint Working Group. JCS/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias. Circ J 2022; 86: 1790–1924.
4. (33) Ogino H, Iida O, Akutsu K, Chiba Y, Hayashi H, Ishibashi-Ueda H, et al.; Japanese Circulation Society, the Japanese Society for Cardiovascular Surgery, the Japanese Association for Thoracic Surgery and the Japanese Society for Vascular Surgery Joint Working Group. JCS/JSCVS/JATS/JSVS 2020 guideline on diagnosis and treatment of aortic aneurysm and aortic dissection. Circ J 2023; 87: 1410–1621.
5. (27) Crea F, Montone RA, Rinaldi R. Pathophysiology of coronary microvascular dysfunction. Circ J 2022; 86: 1319–1328. (Review)
6. (26) Nakano S, Kohsaka S, Chikamori T, Fukushima K, Kobayashi Y, Kozuma K, et al.; JCS Joint Working Group. JCS 2022 guideline focused update on diagnosis and treatment in patients with stable coronary artery disease. Circ J 2022; 86: 882–915.
7. (24) Kusunose K, Kashima S, Sata M. Evaluation of the accuracy of ChatGPT in answering clinical questions on the Japanese society of hypertension guidelines. Circ J 2023; 87: 1030–1033.
8. (20) Ikeda Y, Ako J, Toda K, Hirayama A, Kinugawa K, Kobayashi Y, et al.; J-PVAD Investigators. Short-term outcomes of impella support in Japanese patients with cardiogenic shock due to acute myocardial Infarction-Japanese Registry for Percutaneous Ventricular Assist Device (J-PVAD). Circ J 2023; 87: 588–597.
(20) Nagai T, Inomata T, Kohno T, Sato T, Tada A, Kubo T, et al.; Japanese Circulation Society Joint Working Group. JCS 2023 guideline on the diagnosis and treatment of myocarditis. Circ J 2023; 87: 674–754.
10. (18) Nakamura M, Yaku H, Ako J, Arai H, Asai T, Chikamori T, et al.; Japanese Circulation Society Joint Working Group. JCS/JSCVS 2018 guideline on revascularization of stable coronary artery disease. Circ J 2022; 86: 477–588.
(18) Ohte N, Ishizu T, Izumi C, Itoh H, Iwanaga S, Okura H, et al.; Japanese Circulation Society Joint Working Group. JCS 2021 guideline on the clinical application of echocardiography. Circ J 2022; 86: 2045–2119.
12. (14) Ochi Y, Kubo T, Baba Y, Sugiura K, Miyagawa K, Noguchi T, et al. Early experience of tafamidis treatment in Japanese patients with wild-type transthyretin cardiac amyloidosis from the Kochi amyloidosis cohort. Circ J 2022; 86: 1121–1128.
13. (12) Nogami A, Kurita T, Kusano K, Goya M, Shoda M, Tada H, et al.; Japanese Circulation Society / the Japanese Heart Rhythm Society Joint Working Group. JCS/JHRS 2021 guideline focused update on non-pharmacotherapy of cardiac arrhythmias. Circ J 2022; 86: 337–363.
14. (11) Sun BJ, Park JH. Echocardiographic measurement of left atrial strain: A key requirement in clinical practice. Circ J 2022; 86: 6–13. (Review)
15. (10) Akao M, Ogawa H, Masunaga N, Minami K, Ishigami K, Ikeda S, et al.; Fushimi AF Registry Investigators. 10-year trends of antithrombotic therapy status and outcomes in Japanese atrial fibrillation patients: The Fushimi AF registry. Circ J 2022; 86: 726–736.
(10) Kim DY, Kim MJ, Seo J, Cho I, Shim CY, Hong GR, et al. Predictors of subsequent heart failure after left atrial appendage closure. Circ J 2022; 86: 1129–1136.
17. (9) Muramatsu T, Masuda S, Kotoku N, Kozuma K, Kawashima H, Ishibashi Y, et al. Prasugrel monotherapy after percutaneous coronary intervention with biodegradable-polymer platinum-chromium everolimus eluting stent for Japanese patients with chronic coronary syndrome (ASET-JAPAN). Circ J 2023; 87: 857–865.
18. (8) Hyun J, Kim AR, Lee SE, Hong JA, Kang PJ, Jung SH, et al. Vasoactive-inotropic score as a determinant of timely initiation of venoarterial extracorporeal membrane oxygenation in patients with cardiogenic shock. Circ J 2022; 86: 687–694.
(8) Yokoyama H, Tomita H, Honda S, Nishihira K, Kojima S, Takegami M, et al. Effect of low body mass index on the clinical outcomes of Japanese patients with acute myocardial infarction-results from the prospective Japan acute myocardial infarction registry (JAMIR). Circ J 2022; 86: 632–639.
(8) Kanaoka K, Iwanaga Y, Okada K, Terasaki S, Nishioka Y, Nakai M, et al. Validity of diagnostic algorithms for cardiovascular diseases in Japanese health insurance claims. Circ J 2023; 87: 536–542.
21. (7) Zhou X, Nakamura K, Sahara N, Takagi T, Toyoda Y, Enomoto Y, et al. Deep learning-based recurrence prediction of atrial fibrillation after catheter ablation. Circ J 2022; 86: 299–308.
(7) Ichikawa Y, Oota E, Odajima S, Kintsu M, Todo S, Takeuchi K, et al. Impact of tafamidis on echocardiographic cardiac function of patients with transthyretin cardiac amyloidosis. Circ J 2023; 87: 508–516.
(7) Tilz RR, Vogler J, Kirstein B, Eitel C, Phan HL, Popescu SS, et al. Pulsed field ablation-based pulmonary vein isolation using a simplified single-access single-catheter approach: The fast and furious PFA study. Circ J 2023; 87: 1722–1726.
24. (6) Ono M, Yamaguchi O, Ohtani T, Kinugawa K, Saiki Y, Sawa Y, et al.; JCS/JSCVS/JATS/JSVS Joint Working Group. JCS/JSCVS/JATS/JSVS 2021 guideline on implantable left ventricular assist device for patients with advanced heart failure. Circ J 2022; 86: 1024–1058.
(6) Watanabe R, Nagashima K, Wakamatsu Y, Otsuka N, Yokoyama K, Matsumoto N, et al.; AF Ablation Frontier Registry Investigators. Different determinants of the recurrence of atrial fibrillation and adverse clinical events in the mid-term period after atrial fibrillation ablation. Circ J 2022; 86: 233–242.
(6) Hiraoka E, Tanabe K, Izuta S, Kubota T, Kohsaka S, Kozuki A, et al.; Japanese Society Joint Working Group. JCS 2022 guideline on perioperative cardiovascular assessment and management for non-cardiac surgery. Circ J 2023; 87: 1253–1337.
(6) Masuda M, Asai M, Iida O, Okamoto S, Ishihara T, Nanto K, et al. Low-voltage-area ablation in paroxysmal atrial fibrillation-extended follow-up results of the VOLCANO Trial. Circ J 2022; 86: 245–242.
(6) Izumi C, Miyake M, Fujita T, Koyama T, Tanaka H, Ando K, et al.; BPV-AF Registry Group. Antithrombotic therapy for patients with atrial fibrillation and bioprosthetic valves-real-world data from the multicenter, prospective, observational BPV-AF registry. Circ J 2022; 86: 440–448.
(6) Kodera S, Morita H, Nishi H, Takeda N, Ando J, Komuro I. Cost-effectiveness of dapagliflozin for chronic kidney disease in Japan. Circ J 2022; 86: 2021–2028.
The following papers are the top 44 most frequently cited papers among the 8,338 papers published in the Circulation Journal (2002–2024). Numbers in the parenthesis denote the number of citations.
1. (1530) Matsuzawa Y, Nakamura T, Takahashi M, Ryo M, Inoue S, Ikeda Y, et al. New criteria for ‘obesity disease’ in Japan. Circ J 2002; 66: 987–992. (Review)
2. (596) Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004; 68: 975–981.
3. (594) Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J 2009; 73: 411–418. (Review)
4. (585) Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis: Transition from theory to practice. Circ J 2010; 74: 213–220. (Review)
5. (525) Hori M, Matsumoto M, Tanahashi N, Momomura S, Uchiyama S, Goto S, et al.; on behalf of the J-ROCKET AF study investigators. Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation: The J-ROCKET AF Study. Circ J 2012; 76: 2104–2111.
6. (469) Zhou Q, Liao JK. Pleiotropic effects of statins: Basic research and clinical perspectives. Circ J 2010; 74: 818–826. (Review)
7. (465) Tsutsui H, Isobe M, Ito H, Ito H, Okumura K, Ono M, et al.; the Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group. JCS 2017/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure: Digest version. Circ J 2019; 83: 2084–2184.
8. (460) Lee HY, Oh BH. Aging and arterial stiffness. Circ J 2010; 74: 2257–2262. (Review)
9. (372) Vanhoutte PM. Endothelial dysfunction: The first step toward coronary arteriosclerosis. Circ J 2009; 73: 595–601. (Review)
10. (370) Inoue H, Atarashi H, Kamakura S, Koretsune Y, Kumagai K, Mitamura H, et al.; JCS Joint Working Group. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013): Digest version. Circ J 2014; 78: 1997–2021.
11. (350) Ogawa H, Akasaka T, Hattori R, Inoue T, Kawashima S, Kawasuji M, et al.; JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2013): Digest version. Circ J 2014; 78: 2779–2801.
12. (347) Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, et al.; on behalf of the Japanese Circulation Society Joint Working Group. JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome. Circ J 2019; 83: 1085–1196.
13. (337) Harada M, Van Wagoner DR, Nattel S. Role of inflammation in atrial fibrillation pathophysiology and management. Circ J 2015; 79: 495–502. (Review)
14. (289) Jeong JW, Jeong MH, Yun KH, Oh SK, Park EM, Kim YK, et al. Echocardiographic epicardial fat thickness and coronary artery disease. Circ J 2007; 71: 536–539.
15. (288) Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005; 69: 928–933.
16. (287) Okura Y, Ramadan MM, Ohno Y, Mitsuma W, Tanaka K, Ito M, et al. Impending epidemic: Future projection of heart failure in Japan to the year 2055. Circ J 2008; 72: 489–491.
17. (278) Ando J, Yamamoto K. Vascular mechanobiology: Endothelial cell responses to fluid shear stress. Circ J 2009; 73: 1983–1992. (Review)
18. (269) Saito S, Isshiki T, Kimura T, Ogawa H, Yokoi H, Nanto S, et al. Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: The PRASFIT-ACS study. Circ J 2014; 78: 1684–1692.
19. (264) Tsuchihashi-Makaya M, Hamaguchi S, Kinugawa S, Yokota T, Goto D, Yokoshiki H, et al.; for the JCARECARD Investigators. Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction: A report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD). Circ J 2009; 73: 1893–1900.
20. (258) Sugimura K, Fukumoto Y, Satoh K, Nochioka K, Miura Y, Aoki T, et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J 2012; 76: 485–488.
21. (253) Tomiyama H, Yamashina A. Non-invasive vascular function tests: Their pathophysiological background and clinical application. Circ J 2010; 74: 24–33. (Review)
22. (252) Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al.; Japanese Circulation Society Joint Working Group. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis: Digest version. Circ J 2019; 83: 2329–2388.
23. (244) Ueyama T, Kasamatsu K, Hano T, Yamamoto K, Tsuruo Y, Nishio I. Emotional stress induces transient left ventricular hypocontraction in the rat via activation of cardiac adrenoceptors: A possible animal model of ‘Takotsubo’ cardiomyopathy. Circ J 2002; 66: 712–713.
24. (241) Swift DL, Lavie CJ, Johannsen NM, Arena R, Earnest CP, O’Keefe JH, et al. Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. Circ J 2013; 77: 281–292. (Review)
25. (232) Ando M, Fukuda I, Ito M, Kobayashi T, Masuda M, Miyahara Y, et al.; JCS Joint Working Group. Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (JCS 2009): Digest version. Circ J 2011; 75: 1258–1281.
(232) Kawai S, Kitabatake A, Tomoike H; Takotsubo Cardiomyopathy Study Group. Guidelines for diagnosis of Takotsubo (ampulla) cardiomyopathy. Circ J 2007; 71: 990–992.
27. (228) Kinugasa Y, Kato M, Sugihara S, Hirai M, Yamada K, Yanagihara K, et al. Geriatric nutritional risk index predicts functional dependency and mortality in patients with heart failure with preserved ejection fraction. Circ J 2013; 77: 705–711.
28. (227) Fujita K, Nishizawa H, Funahashi T, Shimomura I, Shimabukuro M. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Circ J 2006; 70: 1437–1442.
29. (220) Nakamura K, Tomaru T, Yamamura S, Miyashita Y, Shirai K, Noike H. Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J 2008; 72: 598–604.
30. (218) Goto S, Huang CH, Park SJ, Emanuelsson H, Kimura T. Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome: Randomized, double-blind, phase III PHILO study. Circ J 2015; 79: 2452–2460.
31. (216) Kamakura T, Makiyama T, Sasaki K, Yoshida Y, Wuriyanghai Y, Chen J, et al. Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circ J 2013; 77: 1307–1314.
32. (214) Curcio A, Torella D, Indolfi C. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: Approach to therapy. Circ J 2011; 75: 1287–1296. (Review)
33. (213) Ogura R, Hiasa Y, Takahashi T, Yamaguchi K, Fujiwara K, Ohara Y, et al. Specific findings of the standard 12-lead ECG in patients with ‘Takotsubo’ cardiomyopathy: Comparison with the findings of acute anterior myocardial infarction. Circ J 2003; 67: 687–690.
34. (210) Nakamura M, Kimura K, Kimura T, Ishihara M, Otsuka F, Kozuma K, et al. JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease. Circ J 2020; 84: 831–865.
(210) Elrod JW, Molkentin JD. Physiologic functions of cyclophilin D and the mitochondrial permeability transition pore. Circ J 2013; 77: 1111–1122. (Review)
36. (209) Kondo T, Nakano Y, Adachi S, Murohara T. Effects of tobacco smoking on cardiovascular disease. Circ J 2019; 83: 1980–1985. (Review)
37. (208) Lee HC, An SG, Lee HW, Park JS, Cha KS, Hong TJ, et al. Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: A pilot study. Circ J 2012; 76: 1750–1760.
38. (207) Angiolillo DJ, Ueno M, Goto S. Basic principles of platelet biology and clinical implications. Circ J 2010; 74: 597–607. (Review)
(207) Nohara R, Adachi H, Goto Y, Hasegawa E, Ishihara S, Itoh H, et al.; JCS Joint Working Group. Guidelines for rehabilitation in patients with cardiovascular disease (JCS 2012): Digest version. Circ J 2014; 78: 2022–2093.
40. (206) Tomiyama H, Koji Y, Yambe M, Shiina K, Motobe K, Yamada J, et al. Brachial-ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome. Circ J 2005; 69: 815–822.
41. (205) Takigiku K, Takeuchi M, Izumi C, Yuda S, Sakata K, Ohte N, et al. Normal range of left ventricular 2-dimensional strain: Japanese ultrasound speckle tracking of the left ventricle (JUSTICE) study. Circ J 2012; 76: 2623–2632.
42. (201) Shokawa T, Imazu M, Yamamoto H, Toyofuku M, Tasaki N, Okimoto T, et al. Pulse wave velocity predicts cardiovascular mortality: Findings from the Hawaii-Los Angeles-Hiroshima study. Circ J 2005; 69: 259–264.
43. (199) Ohira T, Iso H. Cardiovascular disease epidemiology in Asia: An overview. Circ J 2013; 77: 1646–1652. (Review)
44. (197) JCS Joint Working Group. Guidelines for diagnosis and treatment of aortic aneurysm and aortic dissection (JCS 2011): Digest version. Circ J 2013; 77: 789–828.
The Editorial Team looks forward to receiving manuscripts with high scientific impact from all over the world.
